The use of DRAQ7, a far-red dye, eliminated doxorubicin auto-fluorescence interference in cancer cell lines, enabling precise differentiation of apoptotic cells during flow cytometry.
DRAQ7 provides a reliable method for flow cytometric analysis of doxorubicin-treated cells by overcoming the drug's intrinsic autofluorescence.
Abstract Doxorubicin (DOX) is a widely used chemotherapeutic agent that induces apoptosis through DNA intercalation, topoisomerase II inhibition, and oxidative stress. However, its cardiotoxicity is a significant concern. Flow cytometry, particularly with Annexin V/propidium iodide (PI) or Annexin V/7AAD assays, is commonly used to assess DOX-induced cell death. A challenge arises from DOX's intrinsic fluorescence, which interferes with accurate detection. To address this, we successfully used DRAQ7, a far-red dye, in HeLa and other cancer cell lines. As our study demonstrates DRAQ7 eliminates auto-fluorescence interference, this approach offers precise differentiation of apoptotic cells and improving experimental and therapeutic reliability.
Çiftçi et al. (Mon,) conducted a other in Doxorubicin-induced cell death. DRAQ7 was evaluated on Differentiation of apoptotic cells without auto-fluorescence interference. The use of DRAQ7, a far-red dye, eliminated doxorubicin auto-fluorescence interference in cancer cell lines, enabling precise differentiation of apoptotic cells during flow cytometry.